Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01350895

Enrollment

781

Registered

2011-05-10

Start date

2011-02-28

Completion date

2012-04-30

Last updated

2013-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Keywords

Polycystic ovarian syndrome (PCOS)

Brief summary

To study the clinical and biochemical characteristics women with polycystic ovary syndrome (PCOS) in different aged groups.

Detailed description

Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder of reproductive age women, affecting an estimated 9-18% of all women in this age group. To diagnose of PCOS in early life is especially important because it is now thought to increase metabolic and cardiovascular risks. Investigating PCOS is crucial as it is now considered to increase metabolic and cardiovascular risk, thereby impacting the health of women to a much greater extent than previously thought. We are plan using retrospective analysis to evaluate the clinical and biochemical presentation of PCOS in different aged groups.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 46 Years

Healthy volunteers

Yes

Inclusion criteria

* Reproductive age women with sufficient data

Exclusion criteria

* Disorders of uterus (e.g. Asherman's Syndrome, Mullerian agenesis) and chromosomal anomalies (e.g. Turner syndrome) * women who had had menarche at less than 3 years of age, Day 3 FSH \> 15, or who were older than 46 * women with inadequate clinical/biochemical records * and women who had had ovarian cysts or ovarian tumors in ultrasonography examination * pregnancy women

Countries

Taiwan

Outcome results